Skip to main content
Clinical Trials/NCT06618690
NCT06618690Active, not recruitingNot Applicable

Efficacy of a Supervised Exercise Program on Pain, Physical Function, and Quality of Life in Breast Cancer Survivors: Protocol for a Randomized Clinical Trial

Universidad de Burgos1 site in 1 country325 target enrollmentStarted: September 10, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
325
Locations
1
Primary Endpoint
repeated measures ANOVA

Study Overview

Brief Summary

The purpose of this project is to develop a randomized clinical trial to determine the efficacy of a supervised exercise program on pain, physical function and quality of life in female breast cancer survivors

Detailed Description

A randomized, double-blind, clinical trial will be conducted with 325 participants. The intervention group will receive a supervised exercise program for 12 weeks, while the control group will receive no intervention. Participants' pain, physical function and quality of life will be assessed at baseline, post-intervention and 12 weeks post-intervention.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • women between 18 and 65 years of age,
  • women with oncologic treatment completed less than 3 months ago,
  • women without metastasis,
  • women without pathologies that contraindicate exercise,
  • women who have agreed to sign the informed consent form

Exclusion Criteria

  • not attending scheduled sessions to instruct on the exercises to be performed, - being part of other studies,
  • undergoing another type of therapy
  • pregnancy patients.

Outcomes

Primary Outcomes

repeated measures ANOVA

Time Frame: 12 weeks

the range of motion, tone and muscle strength of the group will be measured in 3 measures over the 12 weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials